Effect of Different Local Anesthetic Volumes of Serratus Anterior Plan Block After Video-Assisted Thoracoscopic Surgery
NCT ID: NCT05255536
Last Updated: 2024-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2022-02-15
2024-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Combined Serratus Anterior Plane Block and Thoracic Paravertebral Block
NCT05255562
Comparison of Deep Serratus Anterior Plane Block and Superficial Serratus Anterior Plane Block
NCT05105282
Comparison of Deep Serratus Anterior Plane Block and Combination of Deep and Superficial Serratus Anterior Plane Block
NCT05106283
US-Guided SAPB Versus ESPB on Acute and Chronic Pain After VATS
NCT05160961
Thoracic Paravertebral Block, Erector Spinae Plane Block, and in Combined Paravertebral-erector Spinae Block
NCT04929665
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Serratus Anterior Plan Block with 20 ml %0.25 Bupivacaine
Following the visualization of the anatomical structures, the nerve block needle will be advanced via the in-plane technique above the serratus anterior muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 20 ml 0.25% bupivacaine will be injected into the area.
Serratus Anterior Plan Block with 20 ml
Superficial serratus anterior plane block with 20 ml will be applied to the patients under real-time ultrasound guidance.
Serratus Anterior Plan Block with 30 ml %0.25 Bupivacaine
Following the visualization of the anatomical structures, the nerve block needle will be advanced via the in-plane technique above the serratus anterior muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 30 ml 0.25% bupivacaine will be injected into the area.
Serratus Anterior Plan Block with 30 ml
Superficial serratus anterior plane block with 30 ml will be applied to the patients under real-time ultrasound guidance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serratus Anterior Plan Block with 20 ml
Superficial serratus anterior plane block with 20 ml will be applied to the patients under real-time ultrasound guidance.
Serratus Anterior Plan Block with 30 ml
Superficial serratus anterior plane block with 30 ml will be applied to the patients under real-time ultrasound guidance.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status I-II-III
* BMI 18 to 30 kg/m2
* Elective video assisted thoracoscopic surgery
Exclusion Criteria
* Emergency surgery
* Chronic opioid or analgesic use
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Musa Zengin
Principal İnvestigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Musa Zengin, MD
Role: PRINCIPAL_INVESTIGATOR
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Atatürk Chest Disease and Chest Surgery Training and Research Hospital
Keçiören, Ankara, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E.Kurul-E1-22-2371
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.